Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: Q4QEJ3
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 122 | 126 | PF00656 | 0.312 |
CLV_NRD_NRD_1 | 21 | 23 | PF00675 | 0.517 |
CLV_NRD_NRD_1 | 227 | 229 | PF00675 | 0.499 |
CLV_NRD_NRD_1 | 89 | 91 | PF00675 | 0.464 |
CLV_NRD_NRD_1 | 98 | 100 | PF00675 | 0.503 |
CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.511 |
CLV_PCSK_KEX2_1 | 227 | 229 | PF00082 | 0.414 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.406 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.451 |
CLV_PCSK_KEX2_1 | 98 | 100 | PF00082 | 0.499 |
CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.433 |
CLV_PCSK_PC1ET2_1 | 98 | 100 | PF00082 | 0.350 |
CLV_PCSK_PC7_1 | 223 | 229 | PF00082 | 0.441 |
CLV_PCSK_PC7_1 | 85 | 91 | PF00082 | 0.513 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.422 |
CLV_PCSK_SKI1_1 | 168 | 172 | PF00082 | 0.563 |
CLV_PCSK_SKI1_1 | 211 | 215 | PF00082 | 0.440 |
CLV_PCSK_SKI1_1 | 227 | 231 | PF00082 | 0.377 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.385 |
DEG_SCF_FBW7_1 | 108 | 115 | PF00400 | 0.389 |
DOC_CYCLIN_RxL_1 | 18 | 29 | PF00134 | 0.491 |
DOC_CYCLIN_RxL_1 | 97 | 106 | PF00134 | 0.438 |
DOC_CYCLIN_yCln2_LP_2 | 30 | 36 | PF00134 | 0.400 |
DOC_MAPK_MEF2A_6 | 199 | 206 | PF00069 | 0.407 |
DOC_PP1_RVXF_1 | 19 | 26 | PF00149 | 0.457 |
DOC_PP2B_LxvP_1 | 30 | 33 | PF13499 | 0.399 |
DOC_USP7_MATH_1 | 112 | 116 | PF00917 | 0.407 |
DOC_USP7_MATH_1 | 179 | 183 | PF00917 | 0.675 |
DOC_USP7_MATH_1 | 51 | 55 | PF00917 | 0.351 |
DOC_USP7_UBL2_3 | 205 | 209 | PF12436 | 0.384 |
DOC_WW_Pin1_4 | 108 | 113 | PF00397 | 0.455 |
DOC_WW_Pin1_4 | 36 | 41 | PF00397 | 0.326 |
LIG_14-3-3_CanoR_1 | 22 | 28 | PF00244 | 0.525 |
LIG_14-3-3_CterR_2 | 232 | 236 | PF00244 | 0.391 |
LIG_Actin_WH2_2 | 23 | 39 | PF00022 | 0.326 |
LIG_BIR_III_4 | 189 | 193 | PF00653 | 0.585 |
LIG_BRCT_BRCA1_1 | 53 | 57 | PF00533 | 0.391 |
LIG_deltaCOP1_diTrp_1 | 46 | 56 | PF00928 | 0.362 |
LIG_FHA_1 | 138 | 144 | PF00498 | 0.566 |
LIG_FHA_2 | 120 | 126 | PF00498 | 0.420 |
LIG_FHA_2 | 129 | 135 | PF00498 | 0.370 |
LIG_FHA_2 | 179 | 185 | PF00498 | 0.729 |
LIG_LIR_Gen_1 | 155 | 164 | PF02991 | 0.425 |
LIG_LIR_Gen_1 | 46 | 57 | PF02991 | 0.348 |
LIG_LIR_LC3C_4 | 12 | 15 | PF02991 | 0.563 |
LIG_LIR_Nem_3 | 155 | 160 | PF02991 | 0.527 |
LIG_LIR_Nem_3 | 39 | 45 | PF02991 | 0.375 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.382 |
LIG_LIR_Nem_3 | 54 | 60 | PF02991 | 0.403 |
LIG_SH2_STAP1 | 45 | 49 | PF00017 | 0.456 |
LIG_SH2_STAT3 | 45 | 48 | PF00017 | 0.468 |
LIG_SUMO_SIM_anti_2 | 197 | 204 | PF11976 | 0.356 |
LIG_WRC_WIRS_1 | 52 | 57 | PF05994 | 0.385 |
MOD_CK2_1 | 128 | 134 | PF00069 | 0.372 |
MOD_CK2_1 | 178 | 184 | PF00069 | 0.669 |
MOD_CK2_1 | 204 | 210 | PF00069 | 0.476 |
MOD_Cter_Amidation | 19 | 22 | PF01082 | 0.528 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.510 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.352 |
MOD_GlcNHglycan | 181 | 184 | PF01048 | 0.773 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.395 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.438 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.314 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.749 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.408 |
MOD_N-GLC_1 | 119 | 124 | PF02516 | 0.372 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.498 |
MOD_NEK2_1 | 204 | 209 | PF00069 | 0.452 |
MOD_NEK2_1 | 219 | 224 | PF00069 | 0.354 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.423 |
MOD_NEK2_1 | 61 | 66 | PF00069 | 0.493 |
MOD_Plk_1 | 119 | 125 | PF00069 | 0.382 |
MOD_Plk_1 | 91 | 97 | PF00069 | 0.456 |
MOD_Plk_2-3 | 191 | 197 | PF00069 | 0.477 |
MOD_Plk_4 | 112 | 118 | PF00069 | 0.464 |
MOD_Plk_4 | 51 | 57 | PF00069 | 0.391 |
MOD_Plk_4 | 9 | 15 | PF00069 | 0.496 |
MOD_Plk_4 | 91 | 97 | PF00069 | 0.519 |
MOD_ProDKin_1 | 108 | 114 | PF00069 | 0.453 |
MOD_ProDKin_1 | 36 | 42 | PF00069 | 0.319 |
MOD_SUMO_rev_2 | 26 | 33 | PF00179 | 0.481 |
TRG_DiLeu_BaEn_1 | 134 | 139 | PF01217 | 0.493 |
TRG_DiLeu_BaLyEn_6 | 98 | 103 | PF01217 | 0.401 |
TRG_ER_diArg_1 | 21 | 23 | PF00400 | 0.552 |
TRG_ER_diArg_1 | 227 | 229 | PF00400 | 0.414 |
TRG_ER_diArg_1 | 88 | 90 | PF00400 | 0.474 |
TRG_ER_diArg_1 | 99 | 102 | PF00400 | 0.476 |
TRG_NLS_Bipartite_1 | 84 | 103 | PF00514 | 0.397 |
TRG_NLS_MonoCore_2 | 96 | 101 | PF00514 | 0.433 |
TRG_NLS_MonoExtC_3 | 96 | 101 | PF00514 | 0.397 |
TRG_NLS_MonoExtN_4 | 97 | 103 | PF00514 | 0.425 |
TRG_Pf-PMV_PEXEL_1 | 59 | 63 | PF00026 | 0.382 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I083 | Leptomonas seymouri | 61% | 96% |
A0A1X0NT13 | Trypanosomatidae | 45% | 96% |
A0A3R7KLV2 | Trypanosoma rangeli | 47% | 91% |
A0A3S5H6Z6 | Leishmania donovani | 92% | 100% |
A4H8V1 | Leishmania braziliensis | 77% | 100% |
A4HX70 | Leishmania infantum | 93% | 100% |
C9ZTU2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9ARC7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |